Noninvasive intracellular delivery of functional peptides and proteins.
about
Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's diseaseEnhanced cell-permeant Cre protein for site-specific recombination in cultured cellsApplications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein CargosNuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans.Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitorExtended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3.Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomesPotential use of non-classical pathways for the transport of macromolecular drugs.Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy.Cell penetrating peptide inhibitors of nuclear factor-kappa B.Protective effects of anti-ricin A-chain antibodies delivered intracellularly against ricin-induced cytotoxicity.Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment.Biological applications of protein transduction technology.Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.Manipulation of Cell Cycle and Chromatin Configuration by Means of Cell-Penetrating GemininCarrier-based strategies for targeting protein and peptide drugs to the lungs.Comparative study on transduction and toxicity of protein transduction domains.Peptides targeting protein kinases: strategies and implications.Nuclear transport modulation reduces hypercholesterolemia, atherosclerosis, and fatty liver.Structure, topology, and tilt of cell-signaling peptides containing nuclear localization sequences in membrane bilayers determined by solid-state NMR and molecular dynamics simulation studiesCell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.Can proline-rich polypeptide complex mimic the effect of nerve growth factor?Endocytosis and membrane potential are required for HeLa cell uptake of R.I.-CKTat9, a retro-inverso Tat cell penetrating peptide.A novel functional role for the highly conserved alpha-subunit KVGFFKR motif distinct from integrin alphaIIbbeta3 activation processes.Suppression of gene expression by a cell-permeable Tet repressor.Receptor/transporter-independent targeting of functional peptides across the plasma membrane.Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal MembraneThe telomere binding protein Pot1 maintains haematopoietic stem cell activity with age.Blocking the function of tyrosine phosphatase SHP-2 by targeting its Src homology 2 domains.Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide.Peptides containing membrane-transiting motifs inhibit virus entry.Intracellular drug delivery. Workshop report from the 28th International Symposium on Controlled Release of Bioactive Materials, San Diego, 23-24 June 2001.Characterization of membrane penetration and cytotoxicity of C9orf72-encoding arginine-rich dipeptides
P2860
Q22248091-151F5A87-B219-45E7-B4E1-4E2C49EF8652Q24797478-3989F1D2-01E0-4A80-A499-87341C20E26BQ26769800-22BF6320-F4DA-4F99-9B40-5D1A4DD0FFBFQ30841060-9F63C1C7-3013-4CF7-BE7F-D2244A0D707BQ33560131-140332C9-D5DE-49D3-BED3-1EAFD39B4296Q33713477-9A1262EC-D842-462A-B797-ED05E01A636DQ33897894-75D7C155-8A1D-41A2-A135-942EF2105161Q34048667-CFBEB7CA-25B1-4283-AAC4-F91E59B72F2EQ34075054-49ABAA46-E2C6-4165-9C3B-CA74151D9CC9Q34146195-2B994425-76F6-40A2-AAF2-F6E5E2063128Q34289086-1962DC44-34CB-4A68-8664-CD040FBD4384Q34878690-CAFDC0A1-4D29-47AA-9520-E81898BA063BQ35207622-F4616B1B-A85D-40BC-AB54-846F502681C5Q35565919-683812CB-C542-4EAA-81DC-1CC6AB45703DQ35785197-F00F8332-80ED-47BB-9A08-C164416F758BQ36022293-F15C8A82-BC5B-4E5D-A09D-A7609A1B8BCEQ36250762-11FFBB5A-C98C-4FA7-A568-78B762A9CBF6Q36510057-1206BA9B-BBD5-4DBF-BE8E-9AC2EE1C2EE9Q36659979-FEA544D5-653E-489E-80F4-66125E26C4D6Q36824716-66323858-A860-4044-9D4A-7D72D3DDE60EQ36857817-0705F989-44CA-4431-BED1-DE767DB9C38DQ37668316-92B04D80-D5F3-4B7F-A00E-460EBBBFAD65Q38973809-78F05C57-F22F-405B-99E6-2D820BC32F0BQ40199589-579BD00C-FD48-4B35-B7A0-8B837E9680DCQ40249649-87BA95F1-9057-4E29-ADAC-6DCCA5AE2EF2Q40315427-10829893-8E17-4B1D-A667-3493667F3749Q40603207-BCC13B2E-4D94-4714-906B-821AEFC51248Q40689786-4CC52E2D-D47B-4F4F-AC74-C594E4DA6D8BQ42274657-26B09B54-9344-4687-9A27-F781A30A1F9EQ42798239-A6236E23-6C48-495E-BFFD-39F1CD55B3A1Q44276037-4B6BB18F-9A32-4B0A-AB01-7771C708D11CQ45731678-B3D9C842-4E4D-43B2-814A-B1B49669BBF5Q46493199-796331E0-F37B-49FF-808A-A6234533A13CQ58708220-80A3D04F-052B-4A2B-9021-ED20E866272A
P2860
Noninvasive intracellular delivery of functional peptides and proteins.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Noninvasive intracellular delivery of functional peptides and proteins.
@ast
Noninvasive intracellular delivery of functional peptides and proteins.
@en
Noninvasive intracellular delivery of functional peptides and proteins.
@nl
type
label
Noninvasive intracellular delivery of functional peptides and proteins.
@ast
Noninvasive intracellular delivery of functional peptides and proteins.
@en
Noninvasive intracellular delivery of functional peptides and proteins.
@nl
prefLabel
Noninvasive intracellular delivery of functional peptides and proteins.
@ast
Noninvasive intracellular delivery of functional peptides and proteins.
@en
Noninvasive intracellular delivery of functional peptides and proteins.
@nl
P1476
Noninvasive intracellular delivery of functional peptides and proteins.
@en
P2093
P356
10.1016/S1367-5931(99)80016-7
P577
1999-02-01T00:00:00Z